Fig. 1From: A machine learning framework develops a DNA replication stress model for predicting clinical outcomes and therapeutic vulnerability in primary prostate cancerThe workflow of the present study. (1) Feature selection and machine-learning benchmark were performed in the TCGA-PRAD dataset. (2) A replication stress signature was established and externally validated in 4 independent cohorts. (3) Potential therapeutic targets and drugs were identified through in silico screeningBack to article page